Ozempic vs Mounjaro
Semaglutide vs Tirzepatide · Comparison Guide
Quick Comparison
| Feature | Ozempic | Mounjaro |
|---|---|---|
| Generic Name | Semaglutide | Tirzepatide |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Drug Class | GLP-1 Receptor Agonist | GIP/GLP-1 Receptor Agonist |
| Shared Conditions | Type 2 Diabetes | |
Key Differences: Ozempic vs Mounjaro
Both are weekly injectable medications for type 2 diabetes. Mounjaro is the first dual GIP/GLP-1 receptor agonist; Ozempic is a GLP-1-only agonist. Head-to-head trials (SURPASS-2) showed Mounjaro achieved greater A1C reduction and more weight loss than Ozempic at comparable doses. Both carry thyroid C-cell tumor black box warnings. Mounjaro is newer; Ozempic has more long-term cardiovascular outcome data.
💊 Ozempic (Semaglutide)
- Class: GLP-1 Receptor Agonist
- Manufacturer: Novo Nordisk
- Full Ozempic information →
💊 Mounjaro (Tirzepatide)
- Class: GIP/GLP-1 Receptor Agonist
- Manufacturer: Eli Lilly
- Full Mounjaro information →
Both are weekly injectable medications for type 2 diabetes. Mounjaro is the first dual GIP/GLP-1 receptor agonist; Ozempic is a GLP-1-only agonist. Head-to-head trials (SURPASS-2) showed Mounjaro achieved greater A1C reduction and more weight loss than Ozempic at comparable doses. Both carry thyroid C-cell tumor black box warnings. Mounjaro is newer; Ozempic has more long-term cardiovascular outcome data.
Neither Ozempic nor Mounjaro is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Ozempic and Mounjaro are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Ozempic and Mounjaro both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Ozempic and Mounjaro
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Ozempic and Mounjaro should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.